Atlas Trials

Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer

Clinical trial NCT00380874 · TERMINATED

Trial details

NCT number
NCT00380874
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Chemotherapy-Induced Peripheral Neuropathy
Start date
2007-01-01
Primary completion
2008-03-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.